Search results for "CARDIOVASCULAR DISEASE."

showing 10 items of 2331 documents

Plant sterols from foods in inflammation and risk of cardiovascular disease: a real threat?

2014

High dietary intakes of cholesterol together with sedentary habits have been identified as major contributors to atherosclerosis. The latter has long been considered a cholesterol storage disease; however, today atherosclerosis is considered a more complex disease in which both innate and adaptive immune-inflammatory mechanisms as well as bacteria play a major role, in addition to interactions between the arterial wall and blood components. This scenario has promoted nutritional recommendations to enrich different type of foods with plant sterols (PS) because of their cholesterol-lowering effects. In addition to cholesterol, PS can also be oxidized during food processing or storage, and the…

medicine.medical_specialtyFood HandlingBiological AvailabilityInflammationDiseaseToxicologyBioinformaticschemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumansLiver X receptorInflammationCholesterolPhytosterolPhytosterolsGeneral MedicineAtherosclerosisSterolSterol regulatory element-binding proteinEndocrinologyCholesterolchemistryCardiovascular DiseasesFoodmedicine.symptomCholesterol storageFood ScienceFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association
researchProduct

Cardiovascular disease in primary sjögren’s syndrome

2018

Background A close relationship between rheumatic diseases and cardiovascular disease (CVD) has been reported, accounting for the higher mortality and morbidity observed in these patients. In the last years, it has been clearly reported that patients affected by primary Sjogren's syndrome (pSS) experienced an increased risk of CVD. Objective This review aimed at investigating CVD, traditional cardiovascular (CV) risk factors and possible targeted therapeutic strategies in pSS patients. Method Available literature concerning CV risk factors in pSS patients has been selected and discussed. Conclusion Disease-related characteristics and traditional CV risk factors contribute to observed athero…

medicine.medical_specialtyFuture studiesEndothelial damageDiseaseType 2 diabetesComorbidity030204 cardiovascular system & hematologySjögren syndrome03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineMedicineHumans030212 general & internal medicinePharmacologybusiness.industryRisk FactorGeneral Medicinemedicine.diseaseAtherosclerosisCardiovascular diseaseCardiovascular riskComorbiditySjögren syndromestomatognathic diseasesSettore MED/16 - ReumatologiaAtherosclerosis; Cardiovascular disease; Cardiovascular risk; Comorbidity; Endothelial damage; Sjögren syndrome; PharmacologyIncreased riskSjogren's SyndromeClose relationshipCardiovascular DiseasesAtherosclerosiSjogren sbusinessHuman
researchProduct

Utilizing nutritional genomics to tailor diets for the prevention of cardiovascular disease: a guide for upcoming studies and implementations.

2017

Introduction: Personalized diets based on an individual’s genome to optimize the success of dietary intervention and reduce genetic cardiovascular disease (CVD) risk, is one of the challenges most frequently discussed in the scientific community. Areas covered: The authors gathered literature-based evidence on nutritional genomics and CVD phenotypes, our own results and research experience to provide a critical overview of the current situation of using nutritional genomics to tailor diets for CVD prevention and to propose guidelines for future studies and implementations. Expert commentary: Hundreds of studies on gene-diet interactions determining CVD intermediate (plasma lipids, hypertens…

medicine.medical_specialtyFuture studiesNutritional genomicsMediterranean dietDisease030204 cardiovascular system & hematologyBioinformaticsNutrigeneticsPathology and Forensic MedicineScientific evidence03 medical and health sciences0302 clinical medicineNutrigenomicsMediterranean dietPlasma lipidsGeneticsMedicineHumans030212 general & internal medicineDietary patternsIntensive care medicineMolecular BiologyNutrigeneticsbusiness.industryPrecision nutritionNutrientsCardiovascular diseaseLipidsDietNutrigenomicsCardiovascular DiseasesPersonalized dietsPractice Guidelines as TopicMolecular MedicineGenetic risk scoresbusinessDiet TherapyExpert review of molecular diagnostics
researchProduct

How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks fo…

2020

Familial hypercholesterolemia (FH) is a common genetic disorder of lipid metabolism, still underdiagnosed and undertreated in the general population. Pathology registers could play a crucial role in the creation of a comprehensive and integrated global approach to cover all aspects of this disease. Systematic data collection of patients affected by FH has increased dramatically worldwide in the past few years. Moreover, results from registers already established for the longest time showed their potentialities in the implementation of the knowledge of FH, comparing country-specific approaches and providing real-world data about identification, management and treatment of FH individuals in t…

medicine.medical_specialtyGenotypeFamilial hypercholesterolemiaPopulationFamilial hypercholesterolemiaDisease030204 cardiovascular system & hematologyHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicineGenetic dyslipidaemiasFamilial hypercholesterolemia; Genetic dyslipidaemias; Pathology registersInternal MedicineHumansMedicineGenetic Predisposition to DiseaseRegistries030212 general & internal medicineeducationIntensive care medicineHypolipidemic Agentseducation.field_of_studybusiness.industryGenetic disorderDiagnostic algorithmsGeneral MedicinePathology registersmedicine.diseaseClinical PracticePhenotypeItalyCardiovascular DiseasesHeart Disease Risk FactorsDisease riskIdentification (biology)Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessAlgorithmsAtherosclerosis Supplements
researchProduct

Myocardial Protection by Retrograde Cardioplegic Perfusion in the Presence of Acute Coronary Artery Obstruction: An Experimental Study

1992

To investigate retrograde delivery of cardioplegic solutions as a means of enhancing myocardial protection in the presence of coronary artery occlusion, a two-part experimental model was devised. In part 1 (in vitro) the possibility of retroperfusing the entire myocardium during acute occlusion of the left anterior descending artery (LAD) was assessed. In part 2 (in vivo) acute LAD occlusion was performed in dogs, and during 2 hours of aortic cross-clamping crystalline cardioplegic solution was infused at 20-minute intervals. In group I the infusion was antegrade, via the aortic root, and in group II it was retrograde, via the coronary sinus. Thereafter the LAD snare was released and the do…

medicine.medical_specialtyGroup iiContrast MediaBlood PressureCoronary DiseaseCoronary AngiographyPotassium ChlorideDogsBody WaterHypothermia InducedInternal medicineOcclusionmedicineCarnivoraAnimalscardiovascular diseasesCardioplegic SolutionsAortaCoronary sinusCardioprotectionCardiopulmonary Bypassbiologybusiness.industryMyocardiumFissipediaHeartbiology.organism_classificationCoronary VesselsPerfusionmedicine.anatomical_structureAnesthesiaHeart Arrest Inducedcardiovascular systemCardiologyCardiology and Cardiovascular MedicinebusinessPerfusionArteryScandinavian Journal of Thoracic and Cardiovascular Surgery
researchProduct

Ambient carbon monoxide and daily mortality:a global time-series study in 337 cities

2021

Background Epidemiological evidence on short-term association between ambient carbon monoxide (CO) and mortality is inconclusive and limited to single cities, regions, or countries. Generalisation of results from previous studies is hindered by potential publication bias and different modelling approaches. We therefore assessed the association between short-term exposure to ambient CO and daily mortality in a multicity, multicountry setting. Methods We collected daily data on air pollution, meteorology, and total mortality from 337 cities in 18 countries or regions, covering various periods from 1979 to 2016. All included cities had at least 2 years of both CO and mortality data. We estimat…

medicine.medical_specialtyHealth (social science)OzoneAir pollutionMedicine (miscellaneous)Time Series610 Medicine & health010501 environmental sciencesmedicine.disease_cause01 natural sciencesDaily mortalityArbetsmedicin och miljömedicin03 medical and health scienceschemistry.chemical_compound0302 clinical medicine360 Social problems & social servicesAir PollutionEnvironmental healthEpidemiologyRisk of mortalitymedicineHumansNitrogen dioxide030212 general & internal medicineCities610 Medicine & healthAir quality indexlcsh:Environmental sciences0105 earth and related environmental sciencesMCClcsh:GE1-350PollutantAir PollutantsCarbon MonoxideHealth PolicyPublic Health Environmental and Occupational HealthPublic Health Global Health Social Medicine and EpidemiologyOccupational Health and Environmental HealthParticulatesAmbient carbon monoxideFolkhälsovetenskap global hälsa socialmedicin och epidemiologicarbon monoxide mortalitychemistryCardiovascular DiseasesEnvironmental scienceDeterminantes da Saúde e da DoençaGenotoxicidade Ambiental360 Social problems & social services
researchProduct

Influence of exclusive resistance training on body composition and cardiovascular risk factors in overweight or obese children: a systematic review.

2011

<b><i>Objective: </i></b>Since the last decade, a significant increase in the prevalence of overweight and obesity among children has been reported. Low aerobic fitness and a low compliance with endurance sports in such children are theoretical reasons to favor the use of resistance training in intervention studies, even though positive effects of resistance training on morbidity without accompanying dietary modifications are a matter of debate. In this review we summarize the studies that have shown the isolated effect of resistance training on body composition and cardiovascular risk factors in overweight and obese children. <b><i>Method: </i><…

medicine.medical_specialtyHealth (social science)Strength trainingBlood PressureOverweightWeight Gainlaw.inventionBody Mass IndexRandomized controlled triallawEndurance trainingPhysiology (medical)medicineAerobic exerciseHumansObesityExercisebusiness.industryResistance TrainingBody Fluid Compartmentsmedicine.diseaseObesityAdipose TissueCardiovascular DiseasesPhysical therapyBody CompositionPatient Compliancemedicine.symptombusinessBody mass indexWeight gainObesity facts
researchProduct

Fibrosis markers and CRIM1 increase in chronic heart failure of increasing severity.

2014

AbstractBackground: Fibrosis suppressors/activators in chronic heart failure (CHF) is a topic of investigation.Aim: To quantify serum levels of fibrosis regulators in CHF.Methods: ELISA tests were used to quantify fibrosis regulators, procollagen type-(PIP)I, (PIP)III, collagen-I, III, BMP1,2,3,7, SDF1α, CXCR4, fibulin 1,2,3, BMPER, CRIM1 and BAMBI in 66 CHF (NYHA class I, n = 9; II, n = 34; III n = 23), and in 14 controls.Results: In CHF, TGFβR2, PIPIII, SDF1α and CRIM1 were increased. PIPIII correlated with CRIM1.Conclusions: The BMPs inhibitor CRIM1 is increased and correlates with higher levels of serum PIPIII showing an imbalance in favor of pro-fibrotic mechanisms in CHF.

medicine.medical_specialtyHealth Toxicology and MutagenesisClinical BiochemistryInflammationBiochemistryGastroenterologySeverity of Illness IndexBone morphogenetic protein 1ElectrocardiographyFibrosisInternal medicinemedicineEndothelial dysfunction heart fibrosis inflammationHumanscardiovascular diseasesEndothelial dysfunctionHeart Failurebusiness.industryMembrane ProteinsBone Morphogenetic Protein Receptorsmedicine.diseaseFibulinProcollagen peptidaseHeart failureImmunologyChronic Diseasecardiovascular systemBAMBImedicine.symptombusinesscirculatory and respiratory physiology
researchProduct

Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance

2012

Myocardial infarction is a major cause of death and disability worldwide. Myocardial infarction may represent a major catastrophic event leading to severe hemodynamic failure or sudden death or it may occur repeatedly in patients with established heart disease. In this context, the role of imaging techniques may become useful for the understanding of the determinants in a preclinical setting before acute coronary events, and for an accurate and correct diagnosis of myocardial infarction. Three-dimensional noninvasive imaging techniques, such as Cardiac CT (CCT) and Cardiac MR imaging (CMR) were widely developed in the last two decades. These imaging techniques may provide new insights into …

medicine.medical_specialtyHeart diseaseContext (language use)Coronary Artery DiseaseSudden deathInternal medicineMedicineHumanscardiovascular diseasesMyocardial infarctionPharmacologymedicine.diagnostic_testbusiness.industryCoronary StenosisElectrocardiography in myocardial infarctionMagnetic resonance imagingmedicine.diseaseCoronary arteriesMyocardial infarctionmedicine.anatomical_structurecardiovascular systemCardiologyRadiologyMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessMagnetic Resonance AngiographyTomography Emission-Computed
researchProduct

Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter

2008

Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontains surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, …

medicine.medical_specialtyHeart diseasemedicine.medical_treatmentAdrenergic beta-AntagonistsElectric CountershockPHARMACOLOGICAL THERAPY IN CHILDREN WITH ATRIAL FIBRILLATION AND ATRIAL FLUTTER.Catheter ablationElectrocardiographyPharmacotherapyInternal medicineAtrial FibrillationDrug DiscoverymedicineHumanscardiovascular diseasesChildUltrasonographyPharmacologyFibrillationmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Cardiac Pacing ArtificialAtrial fibrillationCalcium Channel Blockersmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareAtrial fibrillation atrial flutter pharmacological therapy childrenAtrial FlutterChronic DiseaseCatheter Ablationcardiovascular systemCardiologymedicine.symptombusinessAnti-Arrhythmia AgentsElectrocardiographyAtrial flutterCurrent Pharmaceutical Design
researchProduct